Grifols is a leading global healthcare company. Our trusted and innovative plasma-derived medicines, other biopharmaceuticals and solutions in transfusion medicine enable millions of patients around the world to lead more productive lives.
Grifols is also a leader in transfusion medicine, helping ensure the safety of the world’s blood supply. In addition, we provide biological materials, including plasma, for life-science research and further manufacturing, and the company has a comprehensive portfolio of tools, information and services that enable hospitals to efficiently ...
Spanish plasma-derived medicines company Grifols announced that it has successfully completed the refinancing of its 2027 debt maturities through a new credit agreement structured as a Term Loan B ...
Seeking Alpha: Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C.
The addition of the Clayton site in 2011 marked a new milestone for Grifols (GRFS), turning the company into a top-three plasma industry leader and setting the stage for sustained business growth The ...
Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C.
MSN: Grifols, S.A. (GRFS) to Double Plasma Production With New Spain Facility
BARCELONA, Spain, (GLOBE NEWSWIRE) -- Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines, today announced it has ...
Yahoo: Some paid plasma donors 'still pretty comfortable with doing it' after deaths
Add Yahoo as a preferred source to see more of our stories on Google. Deaths of paid plasma donors in Manitoba have sparked calls to ban the practice, but not everyone is on board. (CBC - image credit ...
Some paid plasma donors 'still pretty comfortable with doing it' after deaths
Hey yall! I put together a cool R6 rig for animating in Blender and I figured I’d share it here for anyone who might find it useful since the amount of R6 rigs with both FK and IK on the DevForum are lacking, so I wanted to make the only one you’ll ever need. It supports both IK (Inverse Kinematics) and FK (Forward Kinematics), and you can blend between them with sliders. It has full ...
Descubre las innovadoras soluciones biofarmacéuticas y sanitarias integrales de Grifols centradas en el paciente.
Explore Grifols Poland, a leader in biotechnology and healthcare, dedicated to improving patient lives through innovative therapies and high-quality services.
Grifols is a global healthcare company that has enhanced the health and well-being of people around the world.
Join Grifols to create a lasting impact with your career. Explore opportunities that allow you to contribute to life-saving solutions and innovate for a healthier future.
We trace our roots back to 1909 when Dr. Josep Antoni Grifols i Roig founded the first analysis laboratory in Barcelona: Instituto Central de Análisis Clínicos, Bacteriológicos y Químicos.
The sale of a minority stake of its U.S. Biopharma business by means of an initial public offering (IPO) would raise capital to strengthen the Group’s balance sheet, reduce debt and support investment in its strategic growth priorities, while allowing Grifols to maintain majority ownership of its U.S. Biopharma business The proposed transaction reinforces Grifols’ self-sufficiency vision ...
Contact Grifols for inquiries and support. Our team is here to assist you with information and resources tailored to your needs.
Explore Grifols France for cutting-edge pharmacovigilance and comprehensive medical information to enhance patient safety and treatment outcomes.
SlashGear: How To Create An Additional Facebook Profile (And Why You Might Want To)
How To Create An Additional Facebook Profile (And Why You Might Want To)
BMJ: 120 Antioxidant blood plasma profiles during a period of heigh training loads at altitude in elite athletes
120 Antioxidant blood plasma profiles during a period of heigh training loads at altitude in elite athletes
ascopubs.org: Modulation of the plasma lipidomic profile with simvastatin in metastatic castration-resistant prostate cancer (mCRPC).
Modulation of the plasma lipidomic profile with simvastatin in metastatic castration-resistant prostate cancer (mCRPC).
ascopubs.org: Plasma cytokine profiles and survival outcomes in the 1801 phase 1/2 clinical trial of 9-ING-41 (elraglusib) in patients with advanced cancer.
Plasma cytokine profiles and survival outcomes in the 1801 phase 1/2 clinical trial of 9-ING-41 (elraglusib) in patients with advanced cancer.
LinkedIn has become more than just a networking tool; it’s your digital resume, portfolio, and reputation rolled into one. Yet many professionals don’t realize that their profiles might be doing more ...
The Corner: Grifols plans to make early repayment of €500 million of its 7.5% secured bonds maturing in 2030
Link Securities | Grifols (GRF) plans to make an early repayment of €500 million of its 7.5% senior secured bonds maturing in 2030. This transaction would ...
Grifols plans to make early repayment of €500 million of its 7.5% secured bonds maturing in 2030
Yahoo Finance UK: Assessing Grifols (BME:GRF) Valuation After Recent Share Price Weakness And Perceived Discount
Recent performance context for Grifols Grifols (BME:GRF) has drawn investor attention after a mixed run, with a modest 1 day gain, a negative move over the past week and month, and a deeper decline ...
Assessing Grifols (BME:GRF) Valuation After Recent Share Price Weakness And Perceived Discount
The Globe and Mail: Grifols Refinances 2027 Debt and Extends Maturities with Multi-Billion Term Loan B Package
Detailed price information for Grifols S.A. ADR (GRFS-Q) from The Globe and Mail including charting and trades.
Grifols Refinances 2027 Debt and Extends Maturities with Multi-Billion Term Loan B Package
Business Wire: Grifols S.A. (GRFS) Admits Improper Accounting, Announces Restatements, Shares Decline Again – Hagens Berman
Grifols’ admissions are the latest development since activist short seller Gotham City Research first took aim at the company on Jan. 9, 2024, releasing a scathing report attacking the company’s ...
Grifols S.A. (GRFS) Admits Improper Accounting, Announces Restatements, Shares Decline Again – Hagens Berman
Yahoo Finance: Does Grifols (BME:GRF) Offer Opportunity After Sharp Share Price Declines And Debt Concerns
Does Grifols (BME:GRF) Offer Opportunity After Sharp Share Price Declines And Debt Concerns
Benzinga.com: Brookfield Negotiates Over $10B In Debt Financing For Acquisition Of Spanish Pharma Giant Grifols
The investment firm has approached banks to secure funding to refinance Grifols' existing debt, which includes loans and high-yield bonds. In March, a new report by Gotham City Research questioned the ...